Rutgers Cancer Institute of New Jersey: Building an International Consortium to Enhance Decision Making in Hodgkin Lymphoma
May 30, 2020
May 30, 2020
NEW BRUNSWICK, New Jersey, May 30 -- Rutgers Cancer Institute of New Jersey issued the following news:
A harmonization of 'big data' in examining long-term outcomes with contemporary treatment for pediatric and adult Hodgkin lymphoma patients is yielding a new approach to inform future clinical trial design and enhance clinical decision-making. Results are being shared as part of a poster presentation at the virtual American Society for Clinical Oncology Annual Meeting taking place . . .
A harmonization of 'big data' in examining long-term outcomes with contemporary treatment for pediatric and adult Hodgkin lymphoma patients is yielding a new approach to inform future clinical trial design and enhance clinical decision-making. Results are being shared as part of a poster presentation at the virtual American Society for Clinical Oncology Annual Meeting taking place . . .